AARTIPHARM

Unclassified

Aarti Pharmalabs Limited

₹1,015.90

+29.15(2.95%)
EMA 9: 954.94EMA 21: 924.32RSI: 63.3MACD: 27.42ATR: 43.83
Overlays
RSI (14)

Open

₹983.00

High

₹1,047.25

Low

₹980.75

Close

₹1,015.90

Volume

9,04,116

Aarti Pharmalabs Limited (AARTIPHARM) last closed at ₹1,015.9 on 17 Nov 2026, 3.0% below its 52-week high. Price is above both the 50-day and 200-day averages. Volume in the last session was close to the 20-day average. The scanner currently flags 20-Day High Breakout, Strong Uptrend Alignment.

1 week

+10.3%

1 month

+16.3%

3 months

+17.9%

52-week high

₹1,047.25

-3.0% from high

52-week low

₹585

Volume vs 20-day

1.28×

Active signals

Move is measured from the close on the first day
20-Day High BreakoutBULLISH
Day 3 · since 12 Nov+0.5%
Strong Uptrend AlignmentBULLISH
Day 10 · since 02 Nov+14.3%

Signal history

Past five months · move is the close-to-close change while the signal was on
DatesSignalTypeLastedMove
12 NovVolume BreakoutBULLISH1d—
02 NovEMA Crossover (9/21)BULLISH1d—
02 NovMACD Bullish CrossoverBULLISH1d—
29 OctEMA Crossover (9/21)BULLISH1d—
29 OctVolume BreakoutBULLISH1d—
29 OctMACD Bullish CrossoverBULLISH1d—
29 OctStrong Uptrend AlignmentBULLISH1d—
21 OctMACD Bearish CrossoverBEARISH1d—
19 Oct – 26 OctDowntrend AlignmentBEARISH4d-1.1%
15 OctEMA Death Cross (9/21)BEARISH1d—
29 Sept – 30 Sept20-Day High BreakoutBULLISH2d-2.0%
25 Sept20-Day High BreakoutBULLISH1d—
22 Sept – 23 Sept20-Day High BreakoutBULLISH2d+6.4%
21 Sept – 07 OctStrong Uptrend AlignmentBULLISH12d+12.6%
18 Sept – 23 SeptVolume BreakoutBULLISH4d+14.6%
17 SeptStrong Uptrend AlignmentBULLISH1d—
28 Aug – 08 SeptStrong Uptrend AlignmentBULLISH7d+3.1%
26 AugStrong Uptrend AlignmentBULLISH1d—
24 AugStrong Uptrend AlignmentBULLISH1d—
14 Aug – 20 AugStrong Uptrend AlignmentBULLISH5d-2.6%
10 Aug20-Day High BreakoutBULLISH1d—
10 AugEMA Crossover (9/21)BULLISH1d—
10 Aug – 12 AugVolume BreakoutBULLISH3d+8.0%
10 AugMACD Bullish CrossoverBULLISH1d—
10 Aug – 12 AugRSI Overbought ZoneNEUTRAL3d+8.0%

Technical data for educational purposes only — not investment advice